Ruth O'Regan, MD
Dr. Ruth O'Regan is Associate Professor, Hematology and Oncology at the Emory Winship Cancer Institute and Director of Winship's Translational Breast Cancer Research Program. Before coming to Winship, Dr. O'Regan was at Northwestern University in Chicago where she was an assistant professor of Medicine. While at Northwestern she worked with one of the world's leading authorities, Dr. V. Craig Jordan, studying the mechanisms of selective estrogen receptor modulator or SERM resistance.
Dr. O'Regan is widely published in peer reviewed scientific journals, having published articles in journals, such as Lancet Oncology, the Journal of the National Cancer Institute and the Journal of the American Medical Association. Dr. O'Regan speaks nationally on topics related to breast cancer, including the use of hormonal and targeted therapies. Dr. O'Regan is a current member of the breast cancer scientific committee of the American Society of Clinical Oncology.
A native of Dublin, Ireland, Dr. O'Regan earned her medical degree at University College in Dublin. She conducted a residency in Internal Medicine and a Fellowship in Oncology at the Mater Hospital, in Dublin. She did her U.S. residency and fellowship at Northwestern University, Chicago, and joined the faculty there in 1999. While at Northwestern, she won the Compassionate Care Award from the Women's Board of Northwestern Hospital and the NSABP Young Clinical Investigator Award in 2001.
Jonathan L. Kaufman, MD
Jonathan L. Kaufman, MD is an assistant professor of Hematology and Medical at Emory University School of Medicine and a member of the Winship Cancer Center at Emory University in Atlanta, Georgia. Dr Kaufman received his medical degree from the Medical College of Georgia in Augusta. He subsequently completed a residency in internal medicine and a fellowship in hematology and oncology at Emory University.
Dr Kaufman is an active clinical and translational researcher in the fields of multiple myeloma, lymphoma, and bone marrow transplant. He is a member of the Winship Cancer Institute's Discovery and Developmental Therapeutics Program, chairs the Bone Marrow Transplant Quality Committee, serves on the Emory Institutional Review Board, is the physician leader on the Chemotherapy Safety Committee and is the Associate Director of the Hematology and Medical Oncology Fellowship Program.
Dr Kaufman is actively involved in the American Society of Hematology and the American Society of Clinical Oncology. He has authored or coauthored more than 35 peer-reviewed manuscripts, book chapters, and abstracts. His work has been published in journals such as Blood, Clinical Cancer Research, Journal of Immunology, Leukemia, and Clinical Lymphoma and Myeloma, and he has served as a reviewer for Clinical Lymphoma and Myeloma, Bone Marrow Transplantation, and Leukemia. Dr Kaufman has presented his clinical research on multiple myeloma at invited institutional lectures, as well as national and international Hematology and Oncology conferences.
Jean Wilbourn -- Program Associate